Bactiquant AS
Bactiquant A/S develops and provides technology for the mobile and online surveillance of bacterial contamination levels in water. It offers Mobile Lab, a handheld tool for pollution tracking; and an online solution to quantify the bacteria in water systems. It serves various industries in the areas of aquaculture, data centers, oil and gas, water utility, industry, and pharma. The company was fo… Read more
Bactiquant AS (BACTIQ) - Net Assets
Latest net assets as of June 2025: Dkr8.00 Million DKK
Based on the latest financial reports, Bactiquant AS (BACTIQ) has net assets worth Dkr8.00 Million DKK as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Dkr18.72 Million) and total liabilities (Dkr10.72 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Dkr8.00 Million |
| % of Total Assets | 42.74% |
| Annual Growth Rate | -37.87% |
| 5-Year Change | -92.31% |
| 10-Year Change | N/A |
| Growth Volatility | 69.07 |
Bactiquant AS - Net Assets Trend (2018–2024)
This chart illustrates how Bactiquant AS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bactiquant AS (2018–2024)
The table below shows the annual net assets of Bactiquant AS from 2018 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Dkr689.23K | -95.22% |
| 2023-12-31 | Dkr14.41 Million | +0.74% |
| 2022-12-31 | Dkr14.31 Million | -32.08% |
| 2021-12-31 | Dkr21.06 Million | +134.90% |
| 2020-12-31 | Dkr8.97 Million | -17.18% |
| 2019-12-31 | Dkr10.83 Million | -9.69% |
| 2018-12-31 | Dkr11.99 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bactiquant AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 134.8% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Dkr1.17 Million | 170.46% |
| Other Comprehensive Income | Dkr989.72K | 143.60% |
| Total Equity | Dkr689.23K | 100.00% |
Bactiquant AS Competitors by Market Cap
The table below lists competitors of Bactiquant AS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
POZZI MILANO S.P.A.
F:7TL
|
$4.16K |
|
Song Da No. 9 JSC
VN:SD9
|
$4.16K |
|
ABC BANKING CORPORATION LIMITED
SEM:ABCB
|
$4.16K |
|
NEXTENERGY SOLAR FD
F:5NE
|
$4.16K |
|
TOWNGAS CHINA
MU:PGJ
|
$4.15K |
|
CHEMICAL INDUSTRIES
BE:V1M
|
$4.15K |
|
Living 3D Holdings Inc
PINK:LTDH
|
$4.14K |
|
Opsy Holding AB
F:K6Q
|
$4.13K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bactiquant AS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 14,411,794 to 689,233, a change of -13,722,561 (-95.2%).
- Net loss of 13,722,560 reduced equity.
- Other comprehensive income decreased equity by 685,637.
- Other factors increased equity by 685,636.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Dkr-13.72 Million | -1990.99% |
| Other Comprehensive Income | Dkr-685.64K | -99.48% |
| Other Changes | Dkr685.64K | +99.48% |
| Total Change | Dkr- | -95.22% |
Book Value vs Market Value Analysis
This analysis compares Bactiquant AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 118.21x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 4.76x to 118.21x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | Dkr0.65 | Dkr3.10 | x |
| 2019-12-31 | Dkr0.59 | Dkr3.10 | x |
| 2020-12-31 | Dkr0.62 | Dkr3.10 | x |
| 2021-12-31 | Dkr1.11 | Dkr3.10 | x |
| 2022-12-31 | Dkr0.73 | Dkr3.10 | x |
| 2023-12-31 | Dkr0.70 | Dkr3.10 | x |
| 2024-12-31 | Dkr0.03 | Dkr3.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bactiquant AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1990.99%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -191.25%
- • Asset Turnover: 0.49x
- • Equity Multiplier: 21.32x
- Recent ROE (-1990.99%) is below the historical average (-324.08%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -9.69% | -21.46% | 0.37x | 1.23x | Dkr-2.36 Million |
| 2019 | -2.52% | -4.83% | 0.41x | 1.26x | Dkr-1.36 Million |
| 2020 | -10.95% | -17.91% | 0.51x | 1.19x | Dkr-1.88 Million |
| 2021 | -64.34% | -162.12% | 0.34x | 1.16x | Dkr-15.66 Million |
| 2022 | -99.15% | -114.50% | 0.53x | 1.62x | Dkr-15.62 Million |
| 2023 | -90.92% | -106.51% | 0.48x | 1.77x | Dkr-14.55 Million |
| 2024 | -1990.99% | -191.25% | 0.49x | 21.32x | Dkr-13.79 Million |
Industry Comparison
This section compares Bactiquant AS's net assets metrics with peer companies in the Pollution & Treatment Controls industry.
No peer company data available for comparison.